sentences:  It has subsidiaries in France (Basilea Pharmaceuticals SAS), Germany (Basilea Pharmaceuticals GmbH), Denmark (Basilea Pharmaceuticals A/S), the People's Republic of China (Basilea Pharmaceutica China Ltd), Spain (Basilea Pharmaceuticals Iberia SL), the United Kingdom (Basilea Pharmaceuticals Ltd.), and the United States of America (Basilea Pharmaceuticals Inc.).According to stock filings, it had 196 employees as of June 2007.Among the company’s notable products is Isavuconazole (CRESEMBA), an intravenous and oral antifungal, which received orphan drug status designation by the United States Food and Drug Administration (FDA) in 2013.